Genetic SpA
Genetic S.p.A. is dedicated to the research, development, manufacturing, and marketing of innovative therapeutic solutions aimed at protecting health and improving patients' quality of life. The company emphasizes quality, sustainability, and value of care, with a strong focus on scientific research, innovation, and international growth. It operates manufacturing plants for liquids and solid oral forms, and offers third-party manufacturing and licensing-out services. Present in over 30 European and Extra-EU countries, Genetic collaborates with major pharmaceutical multinationals and invests heavily in R&D to develop high-quality pharmaceutical products and medical devices.
Industries
Nr. of Employees
medium (51-250)
Genetic SpA
Patents
Budesonide 21-phosphate salts and pharmaceutical compositions containing the same
US-12465614-B2
View Details
Budesonide 21-phosphate salts and pharmaceutical compositions containing the same
US-12465614-B2
View DetailsProducts
Sterile liquid ophthalmic and injectable products
Preservative‑free single‑use and multidose sterile liquid and suspension products, including eye drops, nebulisation liquids and sterile injectable suspensions.
Solid oral dosage forms
Capsules, tablets, film‑coated tablets and effervescent tablets, including high‑potency oncology and immunosuppressant products.
Inhalation and spray products
Manufacture of pressurised metered‑dose inhalers (pMDI) and non‑pressurised sprays, including formulation with environmental‑compliant propellants and integrated packaging.
Sterile liquid ophthalmic and injectable products
Preservative‑free single‑use and multidose sterile liquid and suspension products, including eye drops, nebulisation liquids and sterile injectable suspensions.
Solid oral dosage forms
Capsules, tablets, film‑coated tablets and effervescent tablets, including high‑potency oncology and immunosuppressant products.
Inhalation and spray products
Manufacture of pressurised metered‑dose inhalers (pMDI) and non‑pressurised sprays, including formulation with environmental‑compliant propellants and integrated packaging.
Services
End‑to‑end services for formulation development, technology transfer, GMP manufacture, packaging and serialization for pharmaceutical products and medical devices on behalf of third parties.
Supply of licences and concessions and assistance with product registration and regulatory filings for markets served by the company.
Process development services for formulation, scale‑up and industrialisation of pharmaceutical manufacturing processes.
End‑to‑end services for formulation development, technology transfer, GMP manufacture, packaging and serialization for pharmaceutical products and medical devices on behalf of third parties.
Supply of licences and concessions and assistance with product registration and regulatory filings for markets served by the company.
Process development services for formulation, scale‑up and industrialisation of pharmaceutical manufacturing processes.
Expertise Areas
- Sterile drug product manufacturing
- Solid oral dosage manufacturing
- Inhalation product development and manufacture
- High‑potency and cytotoxic drug handling
Key Technologies
- Blow‑Fill‑Seal aseptic filling
- Aseptic fill‑finish processes
- Pressurized metered‑dose inhaler (pMDI) manufacturing
- High‑potency containment and handling